Carnitine acyltransferases and their influence on CoA pools in health and disease

Molecular Aspects of Medicine

Volumn 25, Issue 5-6, 2004, Pages 475-493

  Ramsay, Rona R ^a   Zammit, Victor A ^b  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b HANNAH RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Carnitine; Carnitine acyltransferase; Coenzyme A; Fatty acid oxidation; Mitochondria; Peroxisomes

Indexed keywords

ACETYLCARNITINE; ACETYLSALICYLIC ACID; ACYL COENZYME A; ANTIBIOTIC AGENT; ANTIOXIDANT; BEZAFIBRATE; CARNITINE; CARNITINE ACYLTRANSFERASE; LEVACECARNINE; PROPIONYLCARNITINE; THIOCTIC ACID; VALPROIC ACID;

ACYLATION; ALZHEIMER DISEASE; CARNITINE DEFICIENCY; CARNITINE PALMITOYLTRANSFERASE DEFICIENCY; CELL METABOLISM; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; COGNITION; DEMENTIA; DRUG URINE LEVEL; ENZYME ACTIVITY; ENZYME DEFICIENCY; FATTY ACID METABOLISM; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HEMODIALYSIS PATIENT; HUMAN; INBORN ERROR OF METABOLISM; NONHUMAN; OXIDATION; PROTEIN EXPRESSION; REVIEW; REYE SYNDROME; SPORTS MEDICINE; TREATMENT OUTCOME;

ANIMALS; CARNITINE; CARNITINE ACYLTRANSFERASES; COENZYME A; DISEASE; HEALTH; HUMANS; MITOCHONDRIA;

EID: 4444311812     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2004.06.002     Document Type: Review

References (76)

1. Abbas A.S., Wu G.X., Schulz H. Carnitine acetyltransferase is not a cytosolic enzyme in rat heart and therefore cannot function in the energy-linked regulation of cardiac fatty acid oxidation. J. Mol. Cell. Cardiol. 30:1998;1305-1309
2. Abu-Elheiga L., Matzuk M.M., Abo-Hashema K.A.H., Wakil S.J. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science. 291:2001;2613-2616
3. Ando S., Tadenuma T., Tanaka Y., Fukui F., Kobayashi S., Ohashi Y., Kawabata T. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. J. Neurosci. Res. 66:2001;266-271
4. Arduini A., Mancinelli G., Radatti G.L., Dottori S., Molajoni F., Ramsay R.R. Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatty-acid turnover in intact human erythrocytes. J. Biol. Chem. 267:1992;12673-12681
5. Arrigoni-Martelli E., Caso V. Carnitine protects mitochondria and removes toxic acyls from xenobiotics. Drug Exp. Clin. Res. 27:2001;27-49
6. Aureli T., Di Cocco M.E., Pucetti C., Ricciolini R., Scalibastri M., Miccheli A., Manetti C., Conti F. Acetyl-L-carnitine modulates glucose metabolism and stimulates glycogen synthesis in rat brain. Brain Res. 796:1998;75-81
7. Aureli T., Puccetti C., Di Cocco M.E., Arduini A., Ricciolini R., Scalibastri M., Manetti C., Conti F. Entry of (1,2-C-13(2))acetyl-L-carnitine in liver tricarboxylic acid cycle and lipogenesis - A study by C-13 NMR spectroscopy in conscious, freely moving rats. Eur. J. Biochem. 263:1999;287-293
8. Aureli T., Di Cocco M.E., Capuani G., Ricciolini R., Manetti C., Miccheli A., Conti F. Effect of long-term feeding with acetyl-L-carnitine on the age-related changes in rat brain lipid composition: A study by P-31 NMR spectroscopy. Neurochem. Res. 25:2000;395-399
9. Bartlett K., Pourfarzam M. Defects of beta-oxidation including carnitine deficiency. Mitochondrial Function Dysfunction. 53:2002;469-516
10. Bhuiyan A., Bartlett K., Sherratt H.S.A., Agius L. Effects of Ciprofibrate and 2-5-(4-chlorophenyl)pentyl oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme-activities in rats - relation between hepatic carnitine concentration and carnitine acetyltransferase activity. Biochem. J. 253:1988;337-343
11. Brady P.S., Marine K.A., Brady L.J., Ramsay R.R. Coordinate induction of hepatic mitochondrial and peroxisomal carnitine acyltransferase synthesis by diet and drugs. Biochem. J. 260:1989;93-100
12. Brass E.P. Overview of coenzyme - a metabolism and its role in cellular toxicity. Chem.-Biol. Interact. 90:1994;203-214
13. Brass E., Hoppel C.L. Relationship between acid-soluble carnitine and CoA pools in vivo. Biochem. J. 190:1980;495-504
14. Brass E.P., Ruff L.J. Rat hepatic Coenzyme A is redistributed in response to mitochondrial acyl-coenzyme A accumulation. J. Nutr. 122:1992;2094-2100
15. Bremer J. Carnitine - metabolism and functions. Physiol. Rev. 63:1983;1420-1480
16. Chase J.F.A., Tubbs P.K. Biochem. J. 116:1970;713-720
17. Colucci W.J., Gandour R.D. Carnitine acetyltransferase - a review of its biology, enzymology, and bioorganic chemistry. Bioorg. Chem. 16:1988;307-334
18. Dennis S.C., Gevers W., Opie L.H. Protons in ischemia - where do they come from - where do they go to. J. Mol. Cell. Cardiol. 23:1991;1077-1086
19. Djouadi F., Bonnefont J.P., Thuillier L., Droin V., Khadom N., Munnich A., Bastin J. Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate. Pediatr. Res. 54:2003;446-451
20. Evans A.M., Fornasini G. Pharmacokinetics of L-carnitine. Clin. Pharmacokinet. 42:2003;941-967
21. Faergeman N.J., Knudsen J. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem. J. 323:1997;1-12
22. Felix C., Gillis M., Driedzic W.R., Paulson D.J., Broderick T.L. Effects of propionyl-L-carnitine on isolated mitochondrial function in the reperfused diabetic rat heart. Diabetes Res. Clin. Pract. 53:2001;17-24
23. Ferrari R., De Giuli F. The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure. J. Card. Fail. 3:1997;217-224
24. Fingerhut R., Roschinger W., Muntau A.C., Dame T., Kreischer J., Arnecke R., Superti-Furga A., Troxler H., Liebl B., Olgemoller B., Roscher A.A. Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin. Chem. 47:2001;1763-1768
25. Fontaine M., Briand G., Ser N., Armelin I., Rolland M.O., Degand P., Vamecq J. Metabolic studies in twin brothers with 2-methylacetoacetyl-CoA thiolase deficiency. Clin. Chim. Acta. 255:1996;67-83
26. Fraser F., Zammit V.A. Enrichment of carnitine palmitoyltransferases I and II in the contact sites of rat liver mitochondria. Biochem. J. 329:1998;225-229
27. Gempel K., Kiechl S., Hofmann S., Lochmuller H., Kiechl-Kohlendorfer U., Willeit J., Sperl W., Rettinger A., Bieger I., Pongratz D., Gerbitz K.D., Bauer M.F. Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry. J. Inherit. Metab. Dis. 25:2002;17-27
28. Gobin S., Thuillier L., Jogl G., Faye A., Tong L., Chi M., Bonnefont J.P., Girard J., Prip-Buus C. Functional and structural basis of carnitine palmitoyltransferase 1A deficiency. J. Biol. Chem. 278:2003;50428-50434
29. Gooding J.M., Shayeghi M., Saggerson E.D. Membrane transport of fatty acylcarnitine and free L-carnitine by rat liver microsomes. Eur. J. Biochem. 271:2004;954-961
30. Haap M., Thamer C., Machann J., Tschritter O., Loblein K., Kellerer M., Schick F., Jacob S., Haring H.U., Stumvoll M. Metabolic characterization of a woman homozygous for the Ser113Leu missense mutation in carnitine palmitoyl transferase II. J. Clin. Endocrinol. Metab. 87:2002;2139-2143
31. Hagen T.M., Ingersoll R.T., Wehr C.M., Lykkesfeldt J., Vinarsky V., Bartholomew J.C., Song M.H., Ames B.N. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc. Natl. Acad. Sci. USA. 95:1998;9562-9566
32. Hagen T.M., Liu J.K., Lykkesfeldt J., Wehr C.M., Ingersoll R.T., Vinarsky V., Bartholomew J.C., Ames B.N. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc. Natl. Acad. Sci. USA. 99:2002;1870-1875
33. Heinonen O.J. Carnitine and physical exercise. Sports Med. 22:1996;109-132
34. Hettema E.H., Tabak H.F. Transport of fatty acids and metabolites across the peroxisomal membrane. BBA-Mol. Cell. Biol. Lipids. 1486:2000;18-27
35. Hulsmann W.C., Peschechera A., Serafini F., Ferrari L.E. Release of ischemia in paced rat Langendorff hearts by supply of L-carnitine: Role of endogenous long-chain acylcarnitine. Mol. Cell. Biochem. 156:1996;87-91
36. Idell-Wenger J., Grotyohann L., Neely J. CoA and carnitine distribution in normal and ischemic hearts. J. Biol. Chem. 253:1978;4310-4318
37. Jogl G., Tong L. Crystal structure of carnitine acetyltransferase and implications for the catalytic mechanism and fatty acid transport. Cell. 112:2003;113-122
38. Juliet P.A.R., Balasubramaniam D., Balasubramaniam N., Panneerselvam C. Carnitine: a neuromodulator in aged rats. J. Gerontol. Ser. A-Biol. Sci. Med. Sci. 58:2003;970-974
39. Kerner J., Hoppel C. Genetic disorders of carnitine metabolism and their nutritional management. Annu. Rev. Nutr. 18:1998;179-206
40. Kido Y., Tamai I., Ohnari A., Sai Y., Kagami T., Nezu J., Nikaido H., Hashimoto N., Asano M., Tsuji A. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J. Neurochem. 79:2001;959-969
41. Kuratsune H., Watanabe Y., Yamaguti K., Jacobsson G., Takahashi M., Machii T., Onoe H., Onoe K., Matsumura K., Valind S., Kitani T., Langstrom B. High uptake of 2-(11) acetyl-L-carnitine into the brain: a pet study. Biochem. Biophys. Res. Commun. 231:1997;488-493
42. Kuratsune H., Yamaguti K., Lindh G., Evengard B., Hagberg G., Matsumura K., Iwase M., Onoe H., Takahashi M., Machii T., Kanakura Y., Kitani T., Langstrom B., Watanabe Y. Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. Neuroimage. 17:2002;1256-1265
43. Liu J.K., Killilea D.W., Ames B.N. Age-associated mitochondrial oxidative decay: Improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc. Natl. Acad. Sci. USA. 99:2002;1876-1881
44. Lopaschuk G.D. Targets for modulation of fatty acid oxidation in the heart. Curr. Opin. Investig. Drugs. 5:2004;290-294
45. Lopaschuk G.D., Kantor P.F., Dyck J.R.B. Optimising cardiac metabolism: A new reference approach to the management of ischemic heart disease? Medicographia. 21:1999;109-115
46. Loster H., Keller T., Grommisch J., Grunder W. Effects of L-carnitine and its acetyl and propionyl esters on ATP and PCr levels of isolated rat hearts perfused without fatty acids and investigated by means of P-31-NMR spectroscopy. Mol. Cell. Biochem. 200:1999;93-102
47. Lysiak W., Lilly K., Dilisa F., Toth P.P., Bieber L.L. Quantitation of the effect of L-carnitine on the levels of acid-soluble short-chain acyl-coa and coash in rat-heart and liver-mitochondria. J. Biol. Chem. 263:1988;1151-1156
48. Maughan R.J., King D.S., Lea T. Dietary supplements. J. Sports Sci. 22:2004;95-113
49. Moder M., Kiessling A., Loster H., Bruggemann L. The pattern of urinary acylcarnitines determined by electrospray mass spectrometry: a new tool in the diagnosis of diabetes mellitus. Anal. Bioanal. Chem. 375:2003;200-210
50. Montgomery S.A., Thal L.J., Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int. Clin. Psychopharmacol. 18:2003;61-71
51. Ramsay R.R. The role of the carnitine system in peroxisomal fatty acid oxidation. Am. J. Med. Sci. 318:1999;28-35
52. Ramsay R.R., Gandour R.D., van der Leij F.R. Molecular enzymology of carnitine transfer and transport. Biochim. Biophys. Acta-Protein Struct. Molec. Enzym. 1546:2001;21-43
53. Rebouche C.J., Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Annu. Rev. Nutr. 18:1998;39-61
54. Reszko A.E., Kasumov T., David F., Jobbins K.A., Thomas K.R., Hoppel C.L., Brunengraber H., Des Rosiers C. Peroxisomal fatty acid oxidation is a substantial source of the acetyl moiety of malonyl-coa in rat heart. J. Biol. Chem. 279:2004;19574-19579
55. Retter A.S. Carnitine and its role in cardiovascular disease. Heart Dis. 1:1999;108-113
56. Ricciolini R., Scalibastri M., Kelleher J.K., Carminati P., Calvani M., Arduini A. Role of acetyl-L-carnitine in rat brain lipogenesis: implications for polyunsaturated fatty acid biosynthesis. J. Neurochem. 71:1998;2510-2517
57. Sandor A., Kispal G., Melegh B., Alkonyi I. Release of carnitine from the perfused rat-liver. Biochim. Biophys. Acta. 835:1985;83-91
58. Schonekess B.O., Allard M.F., Lopaschuk G.D. Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ. Res. 77:1995;726-734
59. Sim K.G., Wiley V., Carpenter K., Wilcken B. Carnitine palmitoyltransferase I deficiency in neonate identified by dried blood spot free carnitine and acylcarnitine profile. J. Inherit. Metab. Dis. 24:2001;51-59
60. Spiekerkoetter U., Tokunaga C., Wendel U., Mayatepek E., Exil V., Duran M., Wijburg F.A., Wanders R.J.A., Strauss A.W. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress. Eur. J. Clin. Invest. 34:2004;191-196
61. Stanley W.C., Lopaschuk G.D., Hall J.L., McCormack J.G. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions - potential for pharmacological interventions. Cardiovasc. Res. 33:1997;243-257
62. Steiber A.L., Weatherspoon L.J., Spry L., Davis A.T. Serum carnitine concentrations correlated to clinical outcome parameters in chronic hemodialysis patients. Clin. Nutr. 23:2004;27-34
63. Tahiliani A.G., Keene T., Kaplan R.S. Characterization of the inhibitor sensitivity of the coenzyme-a transport-system in isolated rat-heart mitochondria. J. Bioenerg. Biomembr. 24:1992;635-640
64. Tanaka M., Nakamura F., Mizokawa S., Matsumura A., Matsumura K., Watanabe Y. Role of acetyl-L-carnitine in the brain: revealed by bioradiography. Biochem. Biophys. Res. Commun. 306:2003;1064-1069
65. Terada R., Matsubara T., Koh N., Nakamura J., Hotta N. Effects of propionyl-L-carnitine on cardiac dysfunction in streptozotocin-diabetic rats. Eur. J. Pharmacol. 357:1998;185-191
66. Tomassini V., Pozzilli C., Onesti E., Pasqualetti P., Marinelli F., Pisani A., Fieschi C. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J. Neurol. Sci. 218:2004;103-108
67. Tran T.N., Christophersen B.O. Studies on the transport of acetyl groups from peroxisomes to mitochondria in isolated liver cells oxidizing the polyunsaturated fatty acid 22: 4n-6. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 1533:2001;255-265
68. van der Leij F.R., Huijkman N.C.A., Boomsma C., Kuipers J.R.G., Bartelds B. Genomics of the human carnitine acyltransferase genes. Mol. Genet. Metab. 71:2000;139-153
69. Vanella A., Russo A., Acquaviva R., Campisi A., Di Giacomo C., Sorrenti V., Barcellona M.L. L-Propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol. Toxicol. 16:2000;99-104
70. Vermeulen R.C.W., Scholte H.R. Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome. Psychosom. Med. 66:2004;276-282
71. Vessey D.A., Chen W., Ramsay R.R. Effect of carboxylic-acid xenobiotics and their metabolites on the activity of carnitine acyltransferases. Biochem. J. 279:1991;895-897
72. Winter S.C., Buist N.R.M. Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine. Am. Heart J. 139:2000;S63-S69
73. Wiseman L.R., Brogden R.N. Propionyl-L-carnitine. Drugs Aging. 12:1998;243-248
74. Yamaguti K., Kuratsune H., Watanabe Y., Takahashi M., Nakamoto I., Machii T., Jacobsson G., Onoe H., Matsumura K., Valind S., Langstrom B., Kitani T. Acylcarnitine metabolism during fasting and after refeeding. Biochem. Biophys. Res. Commun. 225:1996;740-746
75. Yaris N., Akyuz C., Coskun T., Buyukpamukcu M. Serum carnitine levels of pediatric cancer patients. Pediatr. Hematol. Oncol. 19:2002;1-8
76. Zammit V.A. Role of malonyl-CoA-sensitive carnitine palmitoyltransferase in the aetiology and treatment of some metabolic complications of diabetes. Diabetes Nutr. Metab. 11:1998;200-211